Cervical cancer is the fourth-ranked cancer in the world and is associated with a large
number of deaths annually. Chemotherapy and radiotherapy are known as the common …

Human papillomavirus (HPV) cofactors for cervical cancer include smoking, multiparity, and
oral contraceptive use, but their mechanisms of action are not fully understood. It is also …

BACKGROUND: This analysis updates mortality in the Oxford-Family Planning Association
(Oxford-FPA) contraceptive study, with emphasis on oral contraceptive (OC) use. STUDY …

OBJECTIVE: Although cervical screening has led to a significant decline of invasive cervical
cancer (ICC) in developed countries, it remains the third leading cause of cancer in women …

Treatment of gynaecological cancer frequently results in the loss of ovarian function and
menopausal symptoms. Symptoms of iatrogenic menopause are usually significantly more …

Human papillomavirus (HPV) infection is thought to be a necessary but not sufficient cause
of most cases of cervical cancer. Since oral contraceptive use for long durations is …

Background: Few population-based studies have investigated premalignant and malignant
cervical abnormalities in Beijing. Methods: A total of 6,385 randomly selected sexually active …

Objective: To compare cervical screening policy, screening uptake, and changes in cervical
cancer incidence and mortality between Australia and the United Kingdom. Design: Analysis …

Background The majority of anal cancer is associated with human papillomavirus (HPV)
infection, yet little is known about women's risk of acquisition of anal HPV infection Methods …

Oncogenic human papillomavirus is the key determinant of cervical cancer, but other risk
factors interact with it to define individual risk. Among these, there is oral contraceptive (OC) …